Techniker Krankenkasse Tender

Contract notice: Open house original discount contracts 2022-02 - etravirine The health insurance funds involved are pursuing the goal of concluding discount agreements with all suitable pharmaceutical companies in accordance with § 130a para. 8 sgb v on the active ingredient etravirine. the contract is concluded as part of the open-house original procedure of the health insurance companies: individual negotiations about the content of the contract are not conducted, uniform conditions apply. the health insurance companies do not guarantee individual contractual partners any exclusivity. the contract period is a maximum of 24 months starting on 04/01/2022. the contract ends on 03/31/2024 at the latest, regardless of the date of the conclusion of the contract. all further information can be found in the participation and contract documents. If the patent expires before March 31, 2024, the contract ends automatically at the end of the month in which the patent expires.You can join this open-house original process at any time during the contract period. Due to the existence of industrial property rights with regard to the contractual active ingredient, the participation and contract documents are only made available to those pharmaceutical companies who offer/market medicinal products for the active ingredient that is the subject of the procedure or who make credible to tk that they sell medicinal products for the active ingredient that is the subject of the procedure within the to offer/market the contract period. with all pharmaceutical companies who meet the requirements according to Appendix 4 to the contract (self-declaration for approval and for the company) and confirm this in electronic form according to § 126a BGB, a contract is concluded. the present announcement does not apply to the Awarding of a public contract within the meaning of the procurement law directive (2014/24/EG) and antitrust procurement law. in the interest of providing interested pharmaceutical companies with information that is as broad as possible, this announcement is made in the supplement to the official gazette of the european union. the procedure designation "open procedure" used in the context of the present announcement text according to number iv.1.1) and the specification of the award criteria according to number ii.2.5) are due to the specifications of the announcement form and have no further meaning. neither this nor the use of the "ted" medium is associated with any submission to public procurement regulations, the validity of which is not mandatory by law or public procurement regulations.